Argent BioPharma Limited (ASX:RGT)

Australia · Delayed Price · Currency is AUD

0.0310

-0.0020 (-6.06%)

Oct 9, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Pharmaceuticals	161.19K	180.57K	891.08K	3.39M	-
Total	161.19K	180.57K	891.08K	3.39M	-

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Slovenia and Others	440.44K	2.85M	3.22M
Malta	13.21K	-	-
Australia and Others	-	-	1.06M
Australia	437.43K	533.54K	-
Israel	-	7.10K	456.60K
Total	891.08K	3.39M	4.73M